Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

239
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
239
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

332
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
332
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

180
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
180
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

143
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
143
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

243
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
243
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characteristics of tuberculosis in elderly adults: A multicenter French study.

Infectious diseases now·2025
Same author

Epidemiology and outcomes of multidrug-resistant tuberculosis in Rwanda.

Infectious diseases now·2025
Same author

National survey on aspiration pneumonia in elderly hospitalized or institutionalized patients in France in 2023.

Infectious diseases now·2025
Same author

Beyond the First Year: Epidemiology and Management of Late-Onset Opportunistic Infections After Kidney Transplantation.

Transplant international : official journal of the European Society for Organ Transplantation·2024
Same author

Immune response to pertussis vaccine in COPD patients.

Scientific reports·2023
Same author

Probenecid, an old β-lactams pharmacokinetic enhancer for a renewed use: A retrospective study.

Infectious diseases now·2022
Same journal

[Abdominal pain, fever and arthralgia in a 49-year-old woman].

La Revue de medecine interne·2026
Same journal

[Cardiorespiratory functional disorders: A transnosologic approach].

La Revue de medecine interne·2026
Same journal

[Diagnostic evaluation for suspected polycythemia].

La Revue de medecine interne·2026
Same journal

Heart involvements in systemic sclerosis beyond pulmonary hypertension: From conduction, rhythm and function defects to coronary artery disease.

La Revue de medecine interne·2026
Same journal

[Acute intermittent porphyria: When diagnostic errance jeopardizes patient health].

La Revue de medecine interne·2026
Same journal

Autosomal dominant polycystic kidney disease: Current perspectives in 2026.

La Revue de medecine interne·2026
See all related articles

Related Experiment Video

Updated: Jul 5, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.8K

[Paradoxical tuberculosis reaction].

L-D Azoulay1, A-L Houist1, E Feredj1

  • 1Service de maladies infectieuses et d'immunologie clinique, CHU de Henri-Mondor, AP-HP, Créteil, France.

La Revue De Medecine Interne
|January 24, 2024
PubMed
Summary
This summary is machine-generated.

Paradoxical tuberculosis reactions, an immune response during treatment, can worsen or create new lesions. Diagnosis requires ruling out treatment failure, with corticosteroids being the primary management strategy.

Keywords:
Anti-TNFCorticosteroidCorticoïdesGranulomatoseGranulomatosisImmune reconstitution inflammatory syndromeParadoxical reactionRéaction paradoxaleSyndrome inflammatoire de reconstitution immuneTuberculoseTuberculosis

More Related Videos

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.1K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.8K

Related Experiment Videos

Last Updated: Jul 5, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.8K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.1K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.8K

Area of Science:

  • Immunology
  • Infectious Diseases
  • Pulmonology

Background:

  • Paradoxical tuberculosis reaction (PTR) is an immune reconstitution inflammatory syndrome (IRIS) that occurs in 5-30% of tuberculosis (TB) patients during anti-TB treatment.
  • PTR is characterized by the worsening of existing lesions or the appearance of new ones, despite effective TB treatment.
  • Diagnosis is often one of exclusion, requiring the elimination of alternative causes like treatment failure, poor compliance, or drug resistance.

Purpose of the Study:

  • To define paradoxical tuberculosis reaction (PTR).
  • To highlight the diagnostic challenges and clinical significance of PTR.
  • To review current understanding of PTR mechanisms and management strategies.

Main Methods:

  • Literature review of paradoxical tuberculosis reaction.
  • Analysis of diagnostic criteria for PTR.
  • Evaluation of current and proposed management strategies for PTR.

Main Results:

  • PTR affects 5-30% of tuberculosis patients, with prevalence varying by infection site and clinical context.
  • Neurological impairment is a significant concern in severe PTR cases.
  • Corticosteroids are the primary treatment, while the role of anti-TNF agents is still under investigation for refractory cases.

Conclusions:

  • Paradoxical tuberculosis reaction is a recognized complication of TB treatment, necessitating careful diagnosis and management.
  • Understanding the underlying mechanisms of PTR is crucial for optimizing treatment strategies.
  • Further research is needed to clarify the role of agents like anti-TNF in managing corticodependent or corticoresistant PTR.